XETRA •
Healthcare •
Drug Manufacturers - General •
Quote as of 07/29/2026 12:11
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization402,475 mln
Float1,764 mln
Earnings Date07/30/2026
EPS
1.80
Stretched
P / E
129
Highly speculative
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.68
Likely reliable
Relative Strength
96
/ 100
Top performer
Debt / Equity
-10.95
Negative equity
Business Description
AbbVie is a global medicines company that develops, manufactures, and sells treatments across a wide range of health conditions, including cancer, autoimmune and inflammatory diseases, neurological disorders, and eye care. Its portfolio includes well-known products such as Skyrizi, Rinvoq, Imbruvica, and Botox, among many others. Founded in 2012 and based in North Chicago, Illinois, the company operates worldwide and continues to invest heavily in research to bring new therapies to patients.
